• Home
• About us
• Contact

• News
• People
• Products
• Deals
• Organisations

• » Follow us on twitter!
• » Get Free Newsletter!

Advertisement

Document › Details

Actelion Ltd.. (10/19/07). "Press Release: Miglustat (Zavesca®) Receives Negative Opinion from the European Committee for Medicinal Products for Human Use for Extension of Indication for Niemann Pick type C". Allschwil.

	Region	EU (European Union)
	Organisation	Actelion Ltd.
	Group	Actelion (Group)
	Organisation 2	CHMP (Committee for Medicinal Products for Human Use) (EU)
	Group	EU (govt)
	Product	Zavesca®

Record changed: 2011-11-25

Advertisement

More documents for Actelion (Group)

• [1] Actelion Ltd.. (11/22/12). "Press Release: Actelion Submits the Registration Dossier for Macitentan (Opsumit) to the European Medicines Agency (EMA)". Allschwil....
• [2] Actelion Ltd.. (10/22/12). "Press Release: Actelion Submits a New Drug Application to the FDA for Macitentan (Opsumit) for the Treatment of Patients with Pulmonary Arterial Hypertension". Allschwil....
• [3] Actelion Ltd.. (10/18/12). "Press Release: Actelion Announces Nine Months 2012 Financial Results. Total Product Sales of CHF 1,298.6 Million, Down 3% in Local Currencies". Allschwil....
• [4] Actelion Ltd.. (7/19/12). "Press Release: Actelion Announces Half Year 2012 Financial Results". Allschwil....
• [5] Actelion Ltd.. (7/12/12). "Press Release: Actelion Announces Cost Saving Initiative to Be Implemented by the End of 2012. Initative Could Result in a Reduction of Up to 135 Positions". Allschwil....
• [6] Actelion Ltd.. (4/30/12). "Press Release: Actelion’s Macitentan Meets Primary Endpoint in Pivotal Phase III SERAPHIN Outcome Study in Patients with Pulmonary Arterial Hypertension". Allschwil....
• [7] Actelion Ltd.. (4/2/12). "Press Release: Japan’s Ministry of Health, Labour and Welfare Grants Approval for Actelion’s Miglustat for the Treatment of Niemann-Pick Type C Disease". Allschwil....
• [8] Actelion Ltd.. (4/2/12). "Press Release: Actelion Provides Update on CRTH2 Program". Allschwil....
• [9] Actelion Ltd.. (2/23/12). "Press Release: Auxilium Pharmaceuticals, Inc. and Actelion Pharmaceuticals Ltd. Enter a Collaboration Agreement for Xiaflex in Canada, Australia, Brazil and Mexico. Actelion Obtains Exclusive Rights for Two Potential Indication...
• [10] Actelion Ltd.. (2/14/12). "Press Release: Actelion Announces Full Year 2011 Financial Results". Allschwil....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

» top

» Imprint  |  » Contact  |  The use of this website requires to accept the disclaimer!   |  A project of [iito] Business Intelligence © 2002-2013. Made in Germany.